Search

everythinglearnresearchcommunity

for

Search:↓

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

A woman's male-like physical changes were caused by two rare ovarian conditions.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Sex hormones, especially androgens, play a key role in causing acne.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.